correct. What’s the profit on $100mil supply of Keytruda?
Essentially Merck is paying peanuts. This is a zero risk equation for them and all the risk is on shareholders.
There’s no risk reduction for shareholders in this deal.running the trial. But $100 mil won’t cover it and all the other things they are doing. They will have to come back to the market again in 12 months.
running the trial. But $100 mil won’t cover it and all the other...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.3¢ |
Change
0.018(4.43%) |
Mkt cap ! $587.6M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 41.5¢ | 39.5¢ | $392.0K | 969.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 140509 | 41.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.5¢ | 202346 | 17 |
View Market Depth
| Last trade - 13.40pm 21/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |